A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with stable-dose methotrexate in patients with active rheumatoid arthritis A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate ...
A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with stable-dose methotrexate in patients with active rheumatoid arthritis A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate ...